Qingyi Wei, PhD

Professor in Population Health Sciences
Professor in Medicine
Member of the Duke Cancer Institute
Campus mail 103858, GSRB1 Room 3015C, Durham, NC 27710
Phone (919) 660-0562
Email address qingyi.wei@duke.edu

Qingyi Wei, MD, PhD, Professor in the Department of Medicine, is Associate Director for Cancer Control and Population Sciences, Co-leader of CCPS and Co-leader of Epidemiology and Population Genomics (Focus Area 1). He is a professor of Medicine and an internationally recognized epidemiologist focused on the molecular and genetic epidemiology of head and neck cancers, lung cancer, and melanoma. His research focuses on biomarkers and genetic determinants for the DNA repair deficient phenotype and variations in cell death. He is Editor-in-Chief of the open access journal "Cancer Medicine" and Associate Editor-in-Chief of the International Journal of Molecular Epidemiology and Genetics.

Area of Expertise: Epidemiology

Education and Training

  • Ph.D., Johns Hopkins Unversity, Bloomberg School of Public Health, 1993
  • B.M., Nanjing Medical University (China), 1983

Publications

Qu, Xiaofei, Liqin Zhao, Ruoxin Zhang, Qingyi Wei, and Mengyun Wang. “Differential microRNA expression profiles associated with microsatellite status reveal possible epigenetic regulation of microsatellite instability in gastric adenocarcinoma.” Ann Transl Med 8, no. 7 (April 2020): 484. https://doi.org/10.21037/atm.2020.03.54.

PMID
32395528
Full Text

Zhou, Bingrong, Yu Chen Zhao, Hongliang Liu, Sheng Luo, Christopher I. Amos, Jeffrey E. Lee, Xin Li, Hongmei Nan, and Qingyi Wei. “Novel Genetic Variants of ALG6 and GALNTL4 of the Glycosylation Pathway Predict Cutaneous Melanoma-Specific Survival.” Cancers (Basel) 12, no. 2 (January 24, 2020). https://doi.org/10.3390/cancers12020288.

PMID
31991610
Full Text

Dai, W., H. Liu, Y. Liu, X. Xu, D. Qian, S. Luo, E. Cho, et al. “Genetic variants in the folate metabolic pathway genes predict cutaneous melanoma-specific survival.” Br J Dermatol, January 18, 2020. https://doi.org/10.1111/bjd.18878.

PMID
31955403
Full Text

Zhang, Chenan, Helen M. Hansen, Eleanor C. Semmes, Julio Gonzalez-Maya, Libby Morimoto, Qingyi Wei, William C. Eward, et al. “Common genetic variation and risk of osteosarcoma in a multi-ethnic pediatric and adolescent population.” Bone 130 (January 2020): 115070. https://doi.org/10.1016/j.bone.2019.115070.

PMID
31525475
Full Text

Wu, Junlong, Meilin Wang, Haitao Chen, Jianfeng Xu, Guiming Zhang, Chengyuan Gu, Qiang Ding, Qingyi Wei, Yao Zhu, and Dingwei Ye. “The Rare Variant rs35356162 in UHRF1BP1 Increases Bladder Cancer Risk in Han Chinese Population.” Front Oncol 10 (2020): 134. https://doi.org/10.3389/fonc.2020.00134.

PMID
32117775
Full Text

Wu, Yufeng, Sen Yang, Hongliang Liu, Sheng Luo, Thomas E. Stinchcombe, Carolyn Glass, Li Su, et al. “Novel genetic variants of KIR3DL2 and PVR involved in immunoregulatory interactions are associated with non-small cell lung cancer survival.” Am J Cancer Res 10, no. 6 (2020): 1770–84.

PMID
32642289
Scholars@Duke

Zhang, Yang, Erich M. Sturgis, Peng Wei, Hongliang Liu, Ziqiao Wang, Yiding Ma, Chuan Liu, Kyle J. Gu, Qingyi Wei, and Guojun Li. “A genetic variant within MDM4 3'UTR miRNA binding site is associated with HPV16-positive tumors and survival of oropharyngeal cancer.” Mol Carcinog 58, no. 12 (December 2019): 2276–85. https://doi.org/10.1002/mc.23116.

PMID
31513313
Full Text

Dai, Wei, Hongliang Liu, Xinyuan Xu, Jie Ge, Sheng Luo, Dakai Zhu, Christopher I. Amos, et al. “Genetic variants in ELOVL2 and HSD17B12 predict melanoma-specific survival.” Int J Cancer 145, no. 10 (November 15, 2019): 2619–28. https://doi.org/10.1002/ijc.32194.

PMID
30734280
Full Text

Fang, Shenying, Tao Xu, Momiao Xiong, Xinke Zhou, Yuling Wang, Lauren E. Haydu, Merrick I. Ross, et al. “Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression.” J Invest Dermatol 139, no. 11 (November 2019): 2352-2358.e3. https://doi.org/10.1016/j.jid.2019.03.1158.

PMID
31176707
Full Text

Li, Haoran, Xiaoxia Tong, Yuan Xu, Mengyun Wang, Hongji Dai, Tingyan Shi, Menghong Sun, Kexin Chen, Xi Cheng, and Qingyi Wei. “Functional genetic variants of RUVBL1 predict overall survival of Chinese patients with epithelial ovarian cancer.” Carcinogenesis 40, no. 10 (October 16, 2019): 1209–19. https://doi.org/10.1093/carcin/bgz092.

PMID
31083717
Full Text

Pages